Pharvaris Ownership | Who Owns Pharvaris?

Pharvaris Ownership Summary

Pharvaris is owned by 99.60% institutional investors, 6.19% insiders. General atlantic is the largest institutional shareholder, holding 13.58% of PHVS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.68% of its assets in Pharvaris shares.

PHVS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pharvaris	99.60%	6.19%	-5.79%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
General atlantic	8.03M	13.58%	$226.88M
Fmr	6.28M	10.62%	$177.54M
Foresite capital management iv	4.78M	8.08%	$134.99M
Venbio partners	4.64M	7.84%	$131.06M
Viking global investors lp	3.65M	6.18%	$103.21M
Eqt fund management s.a r.l.	3.42M	5.79%	$96.75M
Deerfield management company, l.p. (series c)	3.13M	5.28%	$88.31M
Bain capital life sciences investors	2.68M	4.52%	$75.58M
Wellington management group llp	2.12M	3.58%	$59.86M
Paradigm biocapital advisors lp	1.84M	3.36%	$45.80M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Foresite capital management iv	4.78M	56.94%	$134.99M
Venbio partners	4.64M	46.72%	$131.06M
General atlantic	8.03M	10.56%	$226.88M
Eqt fund management s.a r.l.	3.42M	9.48%	$96.75M
Bain capital life sciences investors	2.68M	6.82%	$75.58M
5am venture management	797.60K	6.26%	$22.53M
Saturn v capital management	1.20M	6.15%	$33.94M
Novo	1.75M	4.01%	$49.44M
Commodore capital lp	1.92M	3.14%	$54.21M
Patient square capital lp	493.00K	2.47%	$13.93M

Top Buyers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	1.84M	1.30%	772.58K
Polar capital	781.02K	0.08%	543.05K
Point72 asset management	1.01M	0.04%	295.39K
Wellington management group llp	2.12M	0.01%	213.11K
Integral health asset management	200.00K	0.34%	200.00K

Top Sellers

Holder	Shares	% Assets	Change
Vr adviser	674.60K	0.95%	-1.37M
Ecor1 capital	-	-	-900.00K
Octagon capital advisors lp	165.00K	0.52%	-506.46K
Price t rowe associates inc /md/	442.26K	0.00%	-499.35K
Rosalind advisors	-	-	-223.63K

New Positions

Holder	Shares	% Assets	Change	Value
Integral health asset management	200.00K	0.34%	200.00K	$4.99M
Foresite capital management v	194.13K	2.02%	194.13K	$5.48M
Dv trading	143.97K	0.10%	143.97K	$4.07M
Woodline partners lp	100.00K	0.01%	100.00K	$2.50M
Diadema partners lp	29.32K	0.14%	29.32K	$828.32K

Sold Out

Holder	Change
Daiwa securities group	-213.00
Quarry lp	-442.00
Virtus etf advisers	-3.74K
Ghisallo capital management	-11.25K
Crestline management, lp	-15.82K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	112	3.70%	58,921,412	-0.20%	99	1.11%	46	-35.21%	35	105.88%
Dec 31, 2025	61	-26.51%	31,462,572	-45.61%	50	0.59%	43	-36.76%	6	-25.00%
Sep 30, 2025	82	43.86%	57,719,608	28.45%	105	1.55%	68	161.54%	7	-53.33%
Jun 30, 2025	60	15.38%	45,040,180	0.23%	82	1.20%	28	55.56%	16	14.29%
Mar 31, 2025	1	-98.15%	3,303,381	-92.60%	6	0.09%	-	-100.00%	-	-100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	1.75M	2.68%	2.39K
Fidelity Growth Compy Commingled Pl O	1.24M	2.29%	-
Fidelity Growth Company Fund	1.26M	1.92%	-
Polar Capital Biotech S Inc	803.39K	1.23%	64.05K
Fidelity Select Health Care	800.00K	1.22%	-
Fidelity Small Cap Growth	644.59K	0.99%	-114.88K
Fidelity Advisor Health Care I	500.00K	0.76%	-
Fidelity Growth Company K6	367.46K	0.56%	-2.39K
Fidelity Series Growth Company	358.44K	0.55%	-
T. Rowe Price Health Sciences	331.53K	0.51%	-233.75K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 04, 2026	Nijdam Anna	Principal Accounting Officer	Sell	$82.43K
May 21, 2026	Monges Viviane	-	Sell	$292.85K
May 22, 2026	Nijdam Anna	Principal Accounting Officer	Sell	$169.08K
May 21, 2026	Nijdam Anna	Principal Accounting Officer	Sell	$55.97K
May 21, 2026	Nassif David W.	CFO / CLO	Sell	$303.08K

Insider Transactions Trends

Date	Buy	Sell
2027 Q1	-	-
2026 Q2	-	-
2026 Q1	-	-
2025 Q2	-	-

PHVS Ownership FAQ

Who Owns Pharvaris?

Pharvaris shareholders are primarily institutional investors at 99.60%, followed by 6.19% insiders and -5.79% retail investors. The average institutional ownership in Pharvaris's industry, Biotech Stocks , is 35.75%, which Pharvaris exceeds.

Who owns the most shares of Pharvaris?

Pharvaris’s largest shareholders are General atlantic (8.03M shares, 13.58%), Fmr (6.28M shares, 10.62%), and Foresite capital management iv (4.78M shares, 8.08%). Together, they hold 32.28% of Pharvaris’s total shares outstanding.

Does Blackrock own Pharvaris?

BlackRock is not among the top 10 institutional shareholders of Pharvaris.

Who is Pharvaris’s biggest shareholder by percentage of total assets invested?

Foresite capital management iv is Pharvaris’s biggest shareholder by percentage of total assets invested, with 56.94% of its assets in 4.78M Pharvaris shares, valued at 134.99M$.

Who is the top mutual fund holder of Pharvaris shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Pharvaris shares, with 2.68% of its total shares outstanding invested in 1.75M Pharvaris shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools